Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (4'-ethyl-2-methyl-3-piperidino)propiophenone
2. 4-empp
3. E-0646
4. Eperisone
1. 56839-43-1
2. Eperisone Hcl
3. Myonal
4. Mional
5. Empp
6. Eperisone, Hcl
7. E-646
8. 1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one Hydrochloride
9. Eperisone Hydrochloride [jan]
10. 4'-ethyl-2-methyl-3-piperidinopropiophenone Hydrochloride
11. U38o8u7p6x
12. 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-1-propanone Hydrochloride
13. 1-(4-ethylphenyl)-2-methyl-3-piperidin-1-ylpropan-1-one;hydrochloride
14. Dsstox_cid_27822
15. Dsstox_rid_82585
16. Dsstox_gsid_47844
17. Cas-56839-43-1
18. Ncgc00167973-01
19. (4'-ethyl-2-methyl-3-piperidino)propiophenone
20. Unii-u38o8u7p6x
21. E 0646
22. Epenard (tn)
23. 1-propanone, 1-(4-ethylphenyl)-2-methyl-3-(1-piperidinyl)-, Hydrochloride
24. Eperisonehydrochloride
25. Dw-1030
26. Schembl218337
27. Chembl2360601
28. Dtxsid8047844
29. Eperisone Hydrochloride (jp17)
30. Chebi:31540
31. Bcp11969
32. Hy-b1901
33. Propiophenone, 4'-ethyl-2-methyl-3-piperidino-, Hydrochloride
34. Eperisone Hydrochloride [mi]
35. Tox21_112599
36. Mfcd00941459
37. Akos015843965
38. Tox21_112599_1
39. Ccg-267425
40. Eperisone Hydrochloride [mart.]
41. Ks-5241
42. Eperisone Hydrochloride [who-dd]
43. Ncgc00167973-02
44. Ac-15896
45. Db-052975
46. Cs-0013960
47. E2000
48. Ft-0602324
49. S4877
50. D01671
51. D95097
52. E-2000
53. A831198
54. Q27889924
55. 1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-onehydrochloride
56. 1-(4-ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one Hydrochloride;eperisone Hcl
Molecular Weight | 295.8 g/mol |
---|---|
Molecular Formula | C17H26ClNO |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 5 |
Exact Mass | 295.1702921 g/mol |
Monoisotopic Mass | 295.1702921 g/mol |
Topological Polar Surface Area | 20.3 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 275 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Muscle Relaxants, Central
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Registration Number : 231MF10073
Registrant's Address : No. 2066 Tangkou Road, Economy and Technology Development Zone, Hefei, Anhui Province...
Initial Date of Registration : 2019-03-15
Latest Date of Registration : 2023-01-25
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0153
Address of the Firm : Plot No. L-6, MIDC, Taloja, Dist. Raigad, Maharastra
Registrant Name : Dongbang FTL Co., Ltd.
Registration Date : 2005-08-31
Registration Number : 20050831-46-C-153-02
Manufacturer Name : Dongbang FTL Co., Ltd.@Syn-T...
Manufacturer Address : Gyeonggi-do Hwaseong-si Hyangnam-eup Pharmaceutical Complex 4-gil 78@No. 168 Kai Yuan...
Registrant Name : Handok Co., Ltd.
Registration Date : 2014-07-25
Registration Number : 20050831-46-C-152-01(3)
Manufacturer Name : Eisai Co., Ltd. Kashima plan...
Manufacturer Address : 22 Sunayama, Kamisu-shi, Ibaraki-ken, Japan
Registrant Name : Korea Ezai Co., Ltd.
Registration Date : 2005-08-31
Registration Number : 20050831-46-C-152-01
Manufacturer Name : Eisai Co., Ltd., Kashima Pla...
Manufacturer Address : 22 Sunayama, Kamisu-shi, Ibaraki-ken, Japan
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2005-09-05
Registration Number : 20050905-46-C-154-05
Manufacturer Name : Kotobuki Pharmaceutical Co.,...
Manufacturer Address : 6351, Sakaki-machi, Hanishina-gun, Nagano-ken, Japan (198, Higashikawahara, Kamigonyo...
Registrant Name : Hwaduk Pharmaceutical Co., Ltd.
Registration Date : 2011-08-12
Registration Number : 20050905-46-C-154-05(1)
Manufacturer Name : Kotobuki Pharmaceutical Co. ...
Manufacturer Address : 6351. Sakai-machi, Hanishina-gun, Nagano-ken, Japan (198, Higashikawahara, Kamigonyo,...
Registrant Name : Kukjeon Pharmaceutical Co., Ltd.
Registration Date : 2014-07-18
Registration Number : 20140718-46-C-332-10
Manufacturer Name : Kookjeon Pharmaceutical Co.,...
Manufacturer Address : No. 12, West Xiexin Road, Taicang Port Development Zone, Taicang City, Jiangsu, China...
Registrant Name : Samhwa Biopharm Co., Ltd.
Registration Date : 2005-08-31
Registration Number : 20050831-46-C-156-03
Manufacturer Name : Samhwa Biopharm Co., Ltd.
Manufacturer Address : 150 Hyeop-ro, Siheung-si, Gyeonggi-do
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2013-02-05
Registration Number : 20130205-46-C-306-08
Manufacturer Name : Sharon Bio-Medicine Ltd.
Manufacturer Address : Plot No. L-6, MIDC, Taloja Dist, Raigad, Maharashtra, India
Registrant Name : Palm East Co., Ltd.
Registration Date : 2014-07-03
Registration Number : 20130205-46-C-306-08(1)
Manufacturer Name : Sharon Bio-Medicine Ltd.
Manufacturer Address : Plot No. L-6, MIDC, Taloja Dist, Raigad, Maharashtra, India
Registrant Name : Gapi Bio Co., Ltd.
Registration Date : 2014-09-19
Registration Number : 20140919-46-C-333-11
Manufacturer Name : Syn-Tech Chem.&Pharm.Co.,Ltd...
Manufacturer Address : No.168 Kai Yuan Rd., Hsin-Ying, Tainan City, 73055, Taiwan
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : Fujian South Pharmaceutical Co., Ltd. (Southern Pharmaceutical) was established in September 2001 and is located in Mingxi County, Fujian Province. After 16 years of development, ...
About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...
About the Company : Incorporated in 2011, SNA Health Care Pvt. Ltd., a WHO-GMP Certified API Manufacturing Company involved in the manufacture and export of Active Pharmaceutical Ingredients, Pharmace...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Myonal (eperisone hydrochloride) is a muscle-relaxant which is used to treat neck-shoulder-arm syndrome and Merislon is approved to treat vertigo and dizziness associated with inner-ear disorders.
Lead Product(s): Eperisone Hydrochloride
Therapeutic Area: Neurology Brand Name: Myonal
Study Phase: ApprovedProduct Type: Small molecule
Sponsor: DKSH
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement November 07, 2022
Lead Product(s) : Eperisone Hydrochloride
Therapeutic Area : Neurology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : DKSH
Deal Size : Undisclosed
Deal Type : Agreement
Eisai To Divest Rights For Muscle Relaxant Myonal® And Vertigo And Equilibrium Disturbance Treatm...
Details : Myonal (eperisone hydrochloride) is a muscle-relaxant which is used to treat neck-shoulder-arm syndrome and Merislon is approved to treat vertigo and dizziness associated with inner-ear disorders.
Brand Name : Myonal
Molecule Type : Small molecule
Upfront Cash : Undisclosed
November 07, 2022
Market Place
Reply
17 Oct 2023
Reply
07 Dec 2022
Reply
08 Jun 2022
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?